✦ LIBER ✦

7050 Evidence of psa decrease with fulvestrant acetate in androgen independent prostate cancer (AIPC) patients

✍ Scribed by Blesa, J. Gasent; Candel, V. Alberola; Vidal, O. Juan; Marco, V. Giner; Fuentes, P. Cerezuela

Book ID: 123317949
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 47 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71428-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

863 POSTER A phase II study of BAY 43–90

863 POSTER A phase II study of BAY 43–9006 (sorafenib) in patients with androgen-independent prostate cancer (AIPC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

362 POSTER A phase 2 trial of AP23573, a

362 POSTER A phase 2 trial of AP23573, an mTOR inhibitor, in patients (pts) with taxane-resistant androgen-independent prostate cancer (AIPC)

✍ M.E. Gross; R.J. Amato; M. Mushtaq; G. Wilding; G. Bubley 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABEL

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABELED ANTI- PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) MONOCLONAL ANTIBODY J591 (177Lu-J591) IN PATIENTS (PTS) WITH METASTATIC ANDROGEN-INDEPENDENT PROSTATE CANCER (AIPC)

✍ Bander, Neil H; Nanus, David M; Tagawa, Scott; Vallabhajosula, Shankar; Goldsmit 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB

Evidence for the existence of an organ s

Evidence for the existence of an organ specific, androgen-independent pathway of progression in patients with metastatic prostate cancer

✍ Jer-Tsong Hsieh; Hsi-Chin Wu; Yan Wang; Wei Tao Song; Wei Li; Laury Finn; Christ 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 638 KB

849 Decreasing cancer specific PSA densi

849 Decreasing cancer specific PSA density (CaPSAD) is a hallmark of local prostate tumour progression with prognostic relevance independent of serum PSA, and reflects a systematic alteration in androgen signalling

✍ Corcoran, N.M.; Hong, M.K.H.; Sapre, N.; Nowell, C.J.; Pedersen, J.; Macintyre, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Inhibition of 20S proteasome results in

Inhibition of 20S proteasome results in serum IL-6 and PSA decline in patients (pts) with androgen-independent prostate cancer (AIPCa) treated with the proteasome inhibitor PS-341

✍ C. Papandreou; D. Daliani; R. Millikan; S. Tu; L. Pagliaro; J. Adams; P. Elliot; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 174 KB